165 related articles for article (PubMed ID: 32560678)
1. The influence of antidepressant and psychotherapy treatment adherence on future work leaves for patients with major depressive disorder.
Gaspar FW; Wizner K; Morrison J; Dewa CS
BMC Psychiatry; 2020 Jun; 20(1):320. PubMed ID: 32560678
[TBL] [Abstract][Full Text] [Related]
2. Medication Adherence and Persistence in Patients with Severe Major Depressive Disorder with Psychotic Features: Antidepressant and Second-Generation Antipsychotic Therapy Versus Antidepressant Monotherapy.
Kim-Romo DN; Rascati KL; Richards KM; Ford KC; Wilson JP; Beretvas SN
J Manag Care Spec Pharm; 2016 May; 22(5):588-96. PubMed ID: 27123919
[TBL] [Abstract][Full Text] [Related]
3. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
[TBL] [Abstract][Full Text] [Related]
4. Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany.
Kasper S; Bonelli A; Cattaneo A; Comandini A; Di Dato G; Heiman F; Pegoraro V; Palao D; Roca M; Volz HP
Int J Psychiatry Clin Pract; 2021 Nov; 25(4):393-402. PubMed ID: 34543170
[TBL] [Abstract][Full Text] [Related]
5. Rates and Determinants of Use of Pharmacotherapy and Psychotherapy by Patients With Major Depressive Disorder.
Gaspar FW; Zaidel CS; Dewa CS
Psychiatr Serv; 2019 Apr; 70(4):262-270. PubMed ID: 30630402
[TBL] [Abstract][Full Text] [Related]
6. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
[TBL] [Abstract][Full Text] [Related]
7. Interventions to improve return to work in depressed people.
Nieuwenhuijsen K; Verbeek JH; Neumeyer-Gromen A; Verhoeven AC; Bültmann U; Faber B
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD006237. PubMed ID: 33052607
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
[TBL] [Abstract][Full Text] [Related]
9. The association between antidepressant dosage titration and medication adherence among patients with depression.
Wu CH; Farley JF; Gaynes BN
Depress Anxiety; 2012 Jun; 29(6):506-14. PubMed ID: 22553149
[TBL] [Abstract][Full Text] [Related]
10. Impact of initial medication non-adherence to SSRIs on medical visits and sick leaves.
Aznar-Lou I; Iglesias-González M; Gil-Girbau M; Serrano-Blanco A; Fernández A; Peñarrubia-María MT; Sabés-Figuera R; Murrugarra-Centurión AG; March-Pujol M; Bolívar-Prados M; Rubio-Valera M
J Affect Disord; 2018 Jan; 226():282-286. PubMed ID: 29024901
[TBL] [Abstract][Full Text] [Related]
11. Psychological therapies for treatment-resistant depression in adults.
Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
[TBL] [Abstract][Full Text] [Related]
12. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder.
Wu CH; Erickson SR; Piette JD; Balkrishnan R
Res Social Adm Pharm; 2012; 8(3):193-205. PubMed ID: 21955808
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.
Valuck RJ; Libby AM; Sills MR; Giese AA; Allen RR
CNS Drugs; 2004; 18(15):1119-32. PubMed ID: 15581382
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain.
Roca M; Bonelli A; Cattaneo A; Comandini A; Di Dato G; Heiman F; Pegoraro V; Kasper S; Volz HP; Palao D
Int J Psychiatry Clin Pract; 2023 Mar; 27(1):59-68. PubMed ID: 35801359
[TBL] [Abstract][Full Text] [Related]
15. Psychotherapy and pharmacotherapy in depression.
Powers RH; Kniesner TJ; Croghan TW
J Ment Health Policy Econ; 2002 Dec; 5(4):153-61. PubMed ID: 14578549
[TBL] [Abstract][Full Text] [Related]
16. The association of antidepressant medication adherence with employee disability absences.
Burton WN; Chen CY; Conti DJ; Schultz AB; Edington DW
Am J Manag Care; 2007 Feb; 13(2):105-12. PubMed ID: 17286530
[TBL] [Abstract][Full Text] [Related]
17. Adherence to continuation and maintenance antidepressant use in recurrent depression.
ten Doesschate MC; Bockting CL; Schene AH
J Affect Disord; 2009 May; 115(1-2):167-70. PubMed ID: 18760488
[TBL] [Abstract][Full Text] [Related]
18. Adherence to augmentation therapy for the treatment of major depressive disorder.
Forma F; Liberman JN; Rui P; Ruetsch C
Expert Rev Pharmacoecon Outcomes Res; 2023 Mar; 23(3):327-335. PubMed ID: 36697398
[TBL] [Abstract][Full Text] [Related]
19. Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder.
Ta JT; Sullivan SD; Tung A; Oliveri D; Gillard P; Devine B
J Manag Care Spec Pharm; 2021 Feb; 27(2):223-239. PubMed ID: 33506730
[No Abstract] [Full Text] [Related]
20. Pattern and predictors of sick leave among users of antidepressants: a Danish retrospective register-based cohort study.
Gasse C; Petersen L; Chollet J; Saragoussi D
J Affect Disord; 2013 Dec; 151(3):959-66. PubMed ID: 24035488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
